Upper Austrian Hightechfonds invests in GENSPEED Biotech
With the recent investment in GENSPEED Biotech GmbH, the Upper Austrian Hightechfonds has brought a promising biotech company into its portfolio. GENSPEED is currently starting with the development of a rapid test for COVID-19 from…
GENSPEED is funded by Austrian Research Promotion Agency for development of unique COVID19 rapid test
GENSPEED develops first point of care test that allows to target both, infected and recovered patients.